Gregory Engel, MD
Cardiac Electrophysiology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 5 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
18 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Engel’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A66069 · Current
Licensed to practise in California · since 1998 · expires 2027-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$730,867
Medicare paid this office $730,867 for 1,870 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 87 | $134,794 | $1,515 |
| Long return visit (40+ min) | 446 | $111,947 | $159 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 513 | $110,057 | $189 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 87 | $73,423 | $410 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 66 | $37,479 | $543 |
See all 43 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 87 | $134,794 | $1,515 |
| Long return visit (40+ min) | 446 | $111,947 | $159 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 513 | $110,057 | $189 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 87 | $73,423 | $410 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 66 | $37,479 | $543 |
| Return visit (30+ min) | 212 | $26,454 | $115 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 44 | $24,228 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,050 | $19,916 | $12 |
| New patient visit (60+ min) | 97 | $18,980 | $196 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 35 | $15,991 | $250 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 38 | $15,251 | $246 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 59 | $13,363 | $226 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 186 | $10,493 | $22 |
| Programming of dual lead pacemaker system | 83 | $10,412 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 158 | $9,735 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 45 | $7,698 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 89 | $6,325 | $70 |
| 3d radiographic procedure | 204 | $5,862 | $26 |
| Long return visit (40+ min) | 41 | $5,324 | $121 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 271 | $4,446 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,761 | $104 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 148 | $3,588 | $21 |
| Programming of heart rhythm stimulation after drug infusion | 46 | $2,791 | $58 |
| Interpretation and report of ultrasound of heart | 33 | $2,597 | $76 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 30 | $2,297 | $29 |
| Programming of dual lead implantable defibrillator system | 15 | $2,216 | $92 |
| Heart muscle strain imaging | 48 | $2,197 | $39 |
| Injection, regadenoson, 0.1 mg | 86 | $2,172 | None |
| Programming of single lead pacemaker system | 21 | $2,170 | $62 |
| Programming of multiple lead implantable defibrillator system | 12 | $2,084 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,018 | $144 |
| Heart rhythm recording of continous external ekg over 8-15 days | 146 | $1,934 | $12 |
| Evaluation of implantable heart and blood vessel monitoring system | 23 | $1,691 | $46 |
| Programming of cardiac rhythm monitor system | 21 | $1,679 | $56 |
| External shock to heart to regulate heart beat | 14 | $1,528 | $95 |
| Return visit (30+ min) | 11 | $958 | $87 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 35 | $755 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 35 | $598 | $16 |
| Evaluation of cardiac rhythm monitor system | 11 | $552 | $46 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 35 | $472 | $13 |
| Ultrasound of heart, follow-up | 13 | $286 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $177 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $115 | $3 |
Procedures Medicare counted
| Pacemaker insertion or repair | 18 | More than 69% of doctors who do this |
Who their Medicare patients are
1,870 Original Medicare patients in 2024. Average age 78 · Under 65 1% · 85 and older 22% · Women 43% · Also on Medicaid 3% · Health risk score 1.13. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Atrial fibrillation 45% · Chronic kidney disease 24% · Diabetes 23% · Heart failure 22% · Cancer 18% · Depression 11% · COPD 10% · Stroke 9% · Dementia 5%.
The office billed $3,441,968, Medicare allowed $951,191 and paid $730,867; for 7,417 services of 78 kinds; $2,172 of it was for drugs given in the office and $728,695 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,870 | 7,417 | 78 | 1.13 | $3,441,968 | $730,867 |
| 2023 | 1,960 | 7,700 | 78 | 1.18 | $3,422,445 | $771,087 |
| 2022 | 1,799 | 7,120 | 78 | 1.13 | $3,115,585 | $734,548 |
| 2021 | 1,438 | 6,536 | 78 | 1.17 | $2,805,980 | $696,591 |
| 2020 | 667 | 5,403 | 77 | 1.32 | $2,326,788 | $577,122 |
| 2019 | 687 | 5,777 | 77 | 1.27 | $2,692,262 | $591,602 |
| 2018 | 624 | 4,742 | 78 | 1.30 | $1,970,394 | $457,883 |
| 2017 | 469 | 3,664 | 77 | 1.26 | $1,748,812 | $404,874 |
| 2016 | 504 | 3,390 | 77 | 1.33 | $1,628,892 | $386,807 |
| 2015 | 548 | 4,002 | 77 | 1.43 | $1,932,556 | $505,689 |
| 2014 | 524 | 3,753 | 77 | 1.32 | $1,720,476 | $472,420 |
| 2013 | 507 | 4,304 | 76 | 1.31 | $2,101,719 | $550,299 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 48 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 96 | $148,221 | $1,544 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 563 | $120,570 | $191 |
| Long return visit (40+ min) | 437 | $110,283 | $161 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 97 | $80,559 | $417 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 74 | $39,473 | $533 |
| Return visit (30+ min) | 182 | $21,187 | $112 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 69 | $20,922 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,033 | $20,446 | $13 |
| New patient visit (60+ min) | 103 | $19,810 | $192 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 64 | $19,412 | $181 |
| Injection, regadenoson, 0.1 mg | 96 | $16,345 | None |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 46 | $12,821 | $178 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 52 | $12,130 | $233 |
| Programming of dual lead pacemaker system | 96 | $11,473 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 194 | $10,359 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 166 | $9,612 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 88 | $5,986 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,721 | $108 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 42 | $5,363 | $22 |
| 3d radiographic procedure | 195 | $5,314 | $25 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 166 | $4,377 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,776 | $157 |
| Programming of heart rhythm stimulation after drug infusion | 50 | $3,270 | $65 |
| Interpretation and report of ultrasound of heart | 38 | $3,004 | $79 |
| New patient visit (45+ min) | 16 | $2,372 | $148 |
| Heart rhythm recording of continous external ekg over 8-15 days | 165 | $2,320 | $12 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 30 | $2,210 | $21 |
| Ultrasound of heart, follow-up | 20 | $2,197 | $96 |
| External shock to heart to regulate heart beat | 22 | $2,183 | $95 |
| Heart muscle strain imaging | 50 | $2,148 | $39 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 30 | $2,114 | $31 |
| Programming of single lead pacemaker system | 18 | $1,995 | $66 |
| Programming of cardiac rhythm monitor system | 21 | $1,983 | $58 |
| Long return visit (40+ min) | 12 | $1,569 | $131 |
| Return visit (30+ min) | 13 | $1,155 | $89 |
| Short return visit (20+ min) | 15 | $1,034 | $69 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $955 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 38 | $854 | $22 |
| Insertion of heart rhythm monitor under skin | 11 | $796 | $72 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $743 | $16 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 33 | $682 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $682 | $21 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 33 | $406 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $384 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 38 | $354 | $9 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $319 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $141 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 44 | $129 | $3 |
2022: 47 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 98 | $152,045 | $1,551 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 510 | $107,091 | $191 |
| Long return visit (40+ min) | 428 | $106,389 | $162 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 99 | $82,332 | $418 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 58 | $38,423 | $640 |
| Return visit (30+ min) | 189 | $23,697 | $111 |
| New patient visit (60+ min) | 121 | $23,295 | $193 |
| Injection, regadenoson, 0.1 mg | 99 | $19,201 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 976 | $19,199 | $12 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 44 | $14,677 | $183 |
| Programming of dual lead pacemaker system | 89 | $12,433 | $77 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 52 | $11,514 | $221 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 39 | $8,859 | $164 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 159 | $8,112 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 137 | $7,284 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 95 | $6,454 | $68 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 64 | $5,633 | $24 |
| 3d radiographic procedure | 222 | $5,544 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,628 | $93 |
| Programming of heart rhythm stimulation after drug infusion | 43 | $3,737 | $81 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 135 | $3,405 | $23 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 36 | $3,335 | $22 |
| Programming of multiple lead implantable defibrillator system | 15 | $2,594 | $104 |
| Interpretation and report of ultrasound of heart | 30 | $2,472 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,434 | $174 |
| External shock to heart to regulate heart beat | 23 | $2,381 | $99 |
| Heart muscle strain imaging | 51 | $2,181 | $40 |
| Heart rhythm recording of continous external ekg over 8-15 days | 134 | $2,023 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 78 | $1,972 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 29 | $1,925 | $21 |
| New patient visit (45+ min) | 14 | $1,833 | $131 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,767 | $110 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 24 | $1,694 | $30 |
| Programming of single lead pacemaker system | 18 | $1,678 | $67 |
| Programming of cardiac rhythm monitor system | 16 | $1,565 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,072 | $60 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $1,001 | $48 |
| Insertion of heart rhythm monitor under skin | 13 | $990 | $76 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $878 | $73 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 36 | $798 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 27 | $652 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $635 | $16 |
| Evaluation of cardiac rhythm monitor system | 11 | $602 | $50 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 36 | $533 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 26 | $252 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $142 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $110 | $3 |
2021: 49 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 99 | $157,706 | $1,593 |
| Long return visit (40+ min) | 339 | $96,817 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 391 | $86,352 | $197 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 99 | $82,155 | $421 |
| Return visit (30+ min) | 245 | $30,408 | $106 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 46 | $28,832 | $613 |
| Injection, regadenoson, 0.1 mg | 101 | $19,310 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 831 | $18,539 | $13 |
| New patient visit (60+ min) | 64 | $13,021 | $203 |
| Programming of dual lead pacemaker system | 84 | $11,361 | $73 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 31 | $10,072 | $265 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 40 | $9,516 | $238 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 47 | $8,744 | $182 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 130 | $8,615 | $26 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $8,421 | $468 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 25 | $7,476 | $241 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 108 | $6,857 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 92 | $6,198 | $67 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 52 | $5,768 | $22 |
| 3d radiographic procedure with computerized image postprocessing | 71 | $5,553 | $71 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 35 | $4,066 | $21 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 44 | $3,262 | $72 |
| Programming of heart rhythm stimulation after drug infusion | 32 | $3,255 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,175 | $93 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 114 | $3,058 | $23 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $2,800 | $85 |
| 3d radiographic procedure | 110 | $2,637 | $23 |
| Short return visit (20+ min) | 28 | $2,368 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,353 | $181 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 24 | $2,133 | $32 |
| Programming of single lead pacemaker system | 20 | $2,050 | $60 |
| Heart rhythm recording of continous external ekg over 8-15 days | 113 | $1,932 | $15 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,889 | $99 |
| External shock to heart to regulate heart beat | 17 | $1,711 | $101 |
| Programming of dual lead implantable defibrillator system | 12 | $1,592 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,536 | $70 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 22 | $1,466 | $21 |
| New patient visit (45+ min) | 11 | $1,427 | $130 |
| Heart muscle strain imaging | 25 | $1,178 | $42 |
| Programming of cardiac rhythm monitor system | 16 | $1,133 | $57 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 35 | $854 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $705 | $44 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 18 | $434 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 16 | $384 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $281 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 16 | $260 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $199 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 18 | $181 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $35 | $3 |
2020: 49 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 78 | $127,365 | $1,612 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 306 | $68,043 | $201 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 78 | $66,133 | $419 |
| Long return visit (40+ min) | 282 | $61,882 | $130 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $34,736 | $808 |
| Return visit (30+ min) | 257 | $32,150 | $92 |
| Injection, regadenoson, 0.1 mg | 78 | $14,810 | None |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 46 | $10,693 | $228 |
| New patient visit (60+ min) | 55 | $9,701 | $176 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 409 | $8,501 | $15 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 18 | $7,673 | $365 |
| Telephone medical discussion with physician, 11-20 minutes | 74 | $7,220 | $70 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 113 | $6,806 | $24 |
| Programming of dual lead pacemaker system | 60 | $6,722 | $63 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 17 | $6,208 | $345 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 54 | $6,184 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $6,156 | $228 |
| External ekg recording for more than 48 hours up to 21 days | 167 | $5,402 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 78 | $5,324 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 87 | $5,237 | $25 |
| Programming of heart rhythm stimulation after drug infusion | 38 | $5,216 | $134 |
| Telephone medical discussion with physician, 21-30 minutes | 45 | $5,085 | $102 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 165 | $4,775 | $24 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 35 | $3,820 | $103 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 29 | $3,809 | $22 |
| Short return visit (20+ min) | 60 | $3,685 | $58 |
| 3d radiographic procedure | 117 | $3,004 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,877 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,416 | $186 |
| Anticoagulant management of patient taking warfarin | 11 | $2,401 | $10 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 26 | $2,148 | $31 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 27 | $1,935 | $21 |
| New patient visit (45+ min) | 14 | $1,871 | $134 |
| External shock to heart to regulate heart beat | 16 | $1,746 | $103 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,483 | $93 |
| Programming of single lead pacemaker system | 17 | $1,343 | $54 |
| Interpretation and report of ultrasound of heart | 16 | $1,317 | $82 |
| Programming of dual lead implantable defibrillator system | 11 | $1,265 | $84 |
| Ultrasonic guidance for blood vessel access | 31 | $827 | $13 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $775 | $41 |
| Programming of cardiac rhythm monitor system | 14 | $692 | $46 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 26 | $653 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $535 | $38 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $502 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $339 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 26 | $261 | $9 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 25 | $249 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $146 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $59 | $3 |
2019: 52 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 63 | $99,703 | $1,534 |
| Long return visit (40+ min) | 300 | $67,437 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 295 | $64,309 | $203 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 63 | $54,072 | $416 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 62 | $44,533 | $718 |
| Return visit (30+ min) | 276 | $31,836 | $90 |
| New patient visit (60+ min) | 93 | $17,450 | $188 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 73 | $16,050 | $211 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 527 | $15,075 | $16 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $12,708 | $669 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 53 | $12,316 | $232 |
| Injection, regadenoson, 0.1 mg | 66 | $12,280 | None |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 23 | $9,776 | $362 |
| Programming of dual lead pacemaker system | 78 | $9,367 | $60 |
| Programming of heart rhythm stimulation after drug infusion | 55 | $7,395 | $132 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 16 | $5,654 | $353 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $5,122 | $466 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 51 | $4,888 | $96 |
| External ekg recording for more than 48 hours up to 21 days | 153 | $4,722 | $26 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $4,686 | $94 |
| 3d radiographic procedure | 193 | $4,634 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $4,551 | $68 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 80 | $4,346 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 153 | $4,296 | $23 |
| External shock to heart to regulate heart beat | 34 | $3,851 | $101 |
| Short return visit (20+ min) | 54 | $3,673 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $3,094 | $24 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 25 | $2,944 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,735 | $182 |
| New patient visit (45+ min) | 18 | $2,671 | $148 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 46 | $2,540 | $12 |
| Programming of dual lead implantable defibrillator system | 12 | $2,492 | $78 |
| Ultrasound of heart blood flow, valves and chambers | 40 | $2,184 | $55 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 21 | $1,933 | $36 |
| Anticoagulant management of patient taking warfarin | 11 | $1,897 | $10 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 15 | $1,859 | $103 |
| Interpretation and report of ultrasound of heart | 21 | $1,718 | $82 |
| Programming of single lead pacemaker system | 19 | $1,711 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 21 | $1,650 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $1,276 | $27 |
| Evaluation of implantable heart and blood vessel monitoring system | 17 | $1,110 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $941 | $67 |
| Insertion of heart rhythm monitor under skin | 11 | $863 | $78 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 36 | $835 | $23 |
| Ultrasonic guidance for blood vessel access | 57 | $778 | $13 |
| Evaluation of cardiac rhythm monitor system | 14 | $768 | $33 |
| Programming of cardiac rhythm monitor system | 12 | $699 | $47 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $472 | $17 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 51 | $453 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 36 | $345 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $176 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $82 | $3 |
2018: 45 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 52 | $82,966 | $1,508 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 280 | $58,743 | $195 |
| Long return visit (40+ min) | 241 | $47,698 | $125 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 50 | $40,941 | $386 |
| Return visit (30+ min) | 293 | $34,129 | $88 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 37 | $27,616 | $746 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 459 | $11,868 | $15 |
| Injection, regadenoson, 0.1 mg | 55 | $10,286 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $9,564 | $213 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 39 | $9,553 | $245 |
| New patient visit (60+ min) | 52 | $9,344 | $180 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,523 | $443 |
| Programming of dual lead pacemaker system | 80 | $7,042 | $50 |
| Programming of heart rhythm stimulation after drug infusion | 33 | $4,421 | $134 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 12 | $4,260 | $355 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 61 | $4,181 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,864 | $90 |
| 3d radiographic procedure | 158 | $3,689 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 80 | $3,643 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 110 | $3,247 | $26 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 29 | $3,028 | $104 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 110 | $2,924 | $23 |
| Short return visit (20+ min) | 47 | $2,920 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,794 | $175 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,515 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 56 | $2,347 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 24 | $2,263 | $47 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 22 | $2,141 | $23 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 48 | $2,089 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 35 | $1,909 | $52 |
| Programming of dual lead implantable defibrillator system | 12 | $1,797 | $67 |
| External shock to heart to regulate heart beat | 15 | $1,796 | $95 |
| Interpretation and report of ultrasound of heart | 23 | $1,789 | $78 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 26 | $1,650 | $20 |
| New patient visit (45+ min) | 12 | $1,484 | $124 |
| Programming of single lead pacemaker system | 14 | $1,235 | $40 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $1,196 | $25 |
| Evaluation of implantable heart and blood vessel monitoring system | 21 | $1,175 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $1,068 | $59 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 19 | $413 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 24 | $384 | $16 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 39 | $347 | $6 |
| Ultrasonic guidance for blood vessel access | 20 | $259 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 19 | $175 | $9 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $64 | $3 |
2017: 37 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 63 | $94,787 | $1,458 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $58,494 | $220 |
| Long return visit (40+ min) | 200 | $37,241 | $121 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 61 | $27,367 | $224 |
| Return visit (30+ min) | 218 | $25,794 | $87 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 29 | $22,832 | $737 |
| Injection, regadenoson, 0.1 mg | 61 | $10,932 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 348 | $9,267 | $15 |
| New patient visit (60+ min) | 50 | $8,996 | $180 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 35 | $8,952 | $256 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 34 | $8,593 | $246 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $7,119 | $356 |
| Programming of dual lead pacemaker system | 66 | $6,316 | $51 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 61 | $4,413 | $70 |
| 3d radiographic procedure with computerized image postprocessing | 58 | $4,073 | $66 |
| External ekg recording for more than 48 hours up to 21 days | 114 | $3,571 | $27 |
| Short return visit (20+ min) | 54 | $3,261 | $56 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 114 | $3,162 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,157 | $90 |
| Programming of heart rhythm stimulation after drug infusion | 22 | $2,629 | $120 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 26 | $2,572 | $92 |
| External shock to heart to regulate heart beat | 23 | $2,430 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 48 | $2,227 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,009 | $167 |
| 3d radiographic procedure | 80 | $1,985 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,824 | $57 |
| Programming of dual lead implantable defibrillator system | 12 | $1,661 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $1,633 | $53 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 32 | $1,474 | $25 |
| Programming of single lead pacemaker system | 14 | $1,147 | $42 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $831 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $799 | $26 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 24 | $761 | $12 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 16 | $736 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 21 | $481 | $20 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 34 | $300 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 21 | $205 | $9 |
2016: 40 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 58 | $85,785 | $1,454 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $54,285 | $224 |
| Long return visit (40+ min) | 192 | $36,378 | $120 |
| Return visit (30+ min) | 231 | $26,257 | $86 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 57 | $25,822 | $227 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 32 | $18,528 | $579 |
| Injection, regadenoson, 0.1 mg | 58 | $9,981 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $9,763 | $271 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 311 | $8,057 | $16 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 29 | $7,491 | $258 |
| New patient visit (60+ min) | 43 | $7,462 | $174 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $7,247 | $453 |
| Programming of dual lead pacemaker system | 65 | $6,813 | $50 |
| 3d radiographic procedure with computerized image postprocessing | 84 | $6,316 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,449 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $4,158 | $72 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $3,940 | $358 |
| Short return visit (20+ min) | 48 | $3,386 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,325 | $175 |
| Programming of heart rhythm stimulation after drug infusion | 22 | $2,970 | $135 |
| External ekg recording for more than 48 hours up to 21 days | 74 | $2,210 | $25 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 28 | $2,051 | $73 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 74 | $2,015 | $23 |
| External shock to heart to regulate heart beat | 16 | $1,967 | $109 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 42 | $1,625 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 28 | $1,523 | $54 |
| New patient visit (45+ min) | 11 | $1,517 | $138 |
| Programming of single lead pacemaker system | 12 | $1,290 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 32 | $1,257 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $1,067 | $56 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,061 | $48 |
| 3d radiographic procedure | 44 | $1,008 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system | 15 | $794 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $745 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 23 | $539 | $22 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $497 | $11 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 43 | $413 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 23 | $239 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $179 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $31 | $3 |
2015: 46 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 75 | $116,743 | $1,536 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $65,148 | $245 |
| Long return visit (40+ min) | 196 | $45,145 | $138 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 75 | $36,336 | $241 |
| Return visit (30+ min) | 222 | $30,725 | $98 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $22,623 | $595 |
| New patient visit (60+ min) | 65 | $12,668 | $195 |
| Injection, regadenoson, 0.1 mg | 75 | $12,612 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 347 | $10,486 | $17 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 36 | $9,613 | $267 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $9,011 | $474 |
| Programming of dual lead pacemaker system | 63 | $8,083 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $7,716 | $98 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $6,955 | $366 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 19 | $6,639 | $349 |
| 3d radiographic procedure with computerized image postprocessing | 87 | $6,263 | $65 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $5,800 | $290 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 75 | $5,768 | $76 |
| Programming of heart rhythm stimulation after drug infusion | 23 | $3,368 | $146 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 34 | $3,289 | $97 |
| Short return visit (20+ min) | 45 | $3,112 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,038 | $190 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 36 | $2,996 | $83 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 12 | $2,921 | $225 |
| Interpretation and report of ultrasound of heart | 31 | $2,879 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,648 | $68 |
| External shock to heart to regulate heart beat | 14 | $2,018 | $112 |
| New patient visit (45+ min) | 14 | $2,005 | $143 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 34 | $1,894 | $28 |
| Programming of dual lead implantable defibrillator system | 12 | $1,892 | $79 |
| External ekg recording for more than 48 hours up to 21 days | 58 | $1,663 | $28 |
| Programming of single lead pacemaker system | 15 | $1,653 | $47 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 58 | $1,496 | $25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,429 | $60 |
| Return visit (30+ min) | 17 | $1,324 | $74 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 22 | $1,315 | $31 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $1,227 | $58 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $1,045 | $28 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 65 | $899 | $7 |
| 3d radiographic procedure | 32 | $755 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $662 | $17 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 12 | $650 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $604 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 13 | $337 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 13 | $141 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $120 | $3 |
2014: 41 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 74 | $111,008 | $1,480 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 193 | $48,039 | $230 |
| Long return visit (40+ min) | 160 | $35,045 | $127 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 74 | $34,096 | $229 |
| Return visit (30+ min) | 233 | $33,349 | $92 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 40 | $29,293 | $714 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $18,860 | $496 |
| Injection, regadenoson, 0.1 mg | 75 | $12,624 | None |
| New patient visit (60+ min) | 56 | $10,017 | $179 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 31 | $9,336 | $283 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 285 | $8,534 | $15 |
| 3d radiographic procedure with computerized image postprocessing | 90 | $8,068 | $82 |
| Programming of dual lead pacemaker system | 50 | $6,469 | $53 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 18 | $6,080 | $338 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $5,838 | $88 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 23 | $5,677 | $237 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 75 | $5,485 | $72 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 15 | $5,436 | $362 |
| Short return visit (20+ min) | 74 | $4,956 | $58 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 22 | $4,875 | $212 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $4,503 | $94 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 35 | $2,475 | $71 |
| Programming of heart rhythm stimulation after drug infusion | 16 | $2,202 | $138 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $2,084 | $25 |
| 3d radiographic procedure | 58 | $1,762 | $29 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,736 | $56 |
| Ultrasound of heart blood flow, valves and chambers | 28 | $1,650 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,539 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $1,494 | $28 |
| External shock to heart to regulate heart beat | 12 | $1,328 | $111 |
| Interpretation and report of ultrasound of heart | 22 | $1,233 | $54 |
| Programming of single lead pacemaker system | 12 | $1,185 | $44 |
| Ultrasound of heart blood flow, valves and chambers | 67 | $1,161 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $1,077 | $83 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 40 | $959 | $23 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $857 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $825 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $806 | $27 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $545 | $12 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 36 | $316 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $214 | $3 |
2013: 47 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 100 | $121,473 | $1,191 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 64 | $55,533 | $782 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 100 | $46,878 | $230 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | $44,708 | $187 |
| Long return visit (40+ min) | 154 | $35,727 | $129 |
| Return visit (30+ min) | 212 | $32,960 | $92 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 36 | $18,417 | $512 |
| Injection, regadenoson, 0.1 mg | 102 | $17,416 | None |
| New patient visit (60+ min) | 56 | $10,291 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $9,882 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 261 | $9,682 | $17 |
| 3d radiographic procedure with computerized image postprocessing | 102 | $9,320 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 102 | $7,902 | $76 |
| Programming of dual lead pacemaker system | 51 | $6,985 | $52 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 19 | $6,443 | $322 |
| Short return visit (20+ min) | 84 | $6,030 | $61 |
| Ultrasound of heart with probe in esophagus, with report | 59 | $5,871 | $90 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $5,515 | $345 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 16 | $5,510 | $344 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 22 | $5,321 | $222 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,949 | $450 |
| 3d radiographic procedure | 57 | $3,611 | $62 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $3,109 | $207 |
| Programming of dual lead implantable defibrillator system | 14 | $2,518 | $72 |
| Programming of multiple lead implantable defibrillator system | 11 | $2,401 | $80 |
| External shock to heart to regulate heart beat | 18 | $2,364 | $107 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 31 | $2,362 | $76 |
| Programming of heart rhythm stimulation after drug infusion | 16 | $2,092 | $131 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $1,893 | $79 |
| Interpretation and report of ultrasound of heart | 35 | $1,835 | $52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 38 | $1,801 | $25 |
| New patient visit (45+ min) | 12 | $1,600 | $133 |
| Ultrasound of heart blood flow, valves and chambers | 90 | $1,597 | $16 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 64 | $1,583 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,559 | $62 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,537 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $1,434 | $53 |
| Programming of single lead pacemaker system | 12 | $1,179 | $45 |
| Evaluation of implantable heart and blood vessel monitoring system | 18 | $1,143 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 23 | $1,072 | $25 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $950 | $20 |
| Return visit (30+ min) | 13 | $885 | $68 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $535 | $45 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 41 | $452 | $6 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 13 | $425 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 91 | $324 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $245 | $20 |
Medicaid work
$579 in 2023
Medicaid paid $579 for 42 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 42 | $579 |
| 2023 | 42 | 1 | 15 | $579 |
| 2022 | 12 | 1 | 12 | $127 |
See the largest Medicaid services in earlier years
2022
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $127 |
Drugs they prescribed that Part D paid
$1,292,273
Pharmacies billed $1,292,273 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,646) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
3,604 generic and 1,042 brand-name prescriptions · $1,292,273 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 612 | $762,577 | $1,246 |
| Jardiance | 109 | $123,569 | $1,134 |
| Entresto | 76 | $99,385 | $1,308 |
| Xarelto | 91 | $98,644 | $1,084 |
| Multaq | 26 | $43,501 | $1,673 |
See all 43 drugs
| Eliquis | 612 | $762,577 | $1,246 |
| Jardiance | 109 | $123,569 | $1,134 |
| Entresto | 76 | $99,385 | $1,308 |
| Xarelto | 91 | $98,644 | $1,084 |
| Multaq | 26 | $43,501 | $1,673 |
| Repatha Sureclick | 29 | $41,323 | $1,425 |
| Dofetilide | 46 | $14,701 | $320 |
| Praluent | 15 | $9,872 | $658 |
| Metoprolol | 424 | $6,148 | $15 |
| Atorvastatin | 539 | $5,640 | $10 |
| Diltiazem 24hr Er (Cd) | 132 | $4,938 | $37 |
| Losartan | 337 | $4,290 | $13 |
| Rosuvastatin | 219 | $3,671 | $17 |
| Ezetimibe | 74 | $2,795 | $38 |
| Flecainide Acetate | 62 | $2,700 | $44 |
| Valsartan | 95 | $2,513 | $26 |
| Carvedilol | 144 | $2,101 | $15 |
| Amlodipine Besylate | 291 | $1,941 | $7 |
| Spironolactone | 163 | $1,810 | $11 |
| Spironolactone-Hctz | 37 | $1,483 | $40 |
| Lisinopril | 142 | $1,209 | $9 |
| Potassium Chloride | 53 | $1,169 | $22 |
| Hydrochlorothiazide | 158 | $1,085 | $7 |
| Toprol Xl | 14 | $1,046 | $75 |
| Furosemide | 131 | $1,041 | $8 |
| Eplerenone | 20 | $795 | $40 |
| Olmesartan Medoxomil | 28 | $743 | $27 |
| Clopidogrel | 42 | $651 | $15 |
| Diltiazem 24hr Er | 17 | $595 | $35 |
| Diltiazem 24hr Er (Xr) | 12 | $583 | $49 |
| Digoxin | 17 | $556 | $33 |
| Irbesartan | 18 | $547 | $30 |
| Sotalol | 29 | $493 | $17 |
| Valsartan-Hydrochlorothiazide | 15 | $427 | $28 |
| Sotalol Af | 29 | $362 | $12 |
| Bisoprolol | 15 | $299 | $20 |
| Simvastatin | 35 | $285 | $8 |
| Metoprolol | 59 | $275 | $5 |
| Warfarin | 18 | $158 | $9 |
| Amiodarone | 12 | $144 | $12 |
| Pindolol | 11 | $96 | $9 |
| Atenolol | 26 | $79 | $3 |
| Lisinopril-Hydrochlorothiazide | 11 | $58 | $5 |
Year by year
| 2024 | 4,646 | 569 | 0% (0) | 22% | $1,292,273 |
| 2023 | 4,267 | 517 | 0% (0) | 21% | $1,126,473 |
| 2022 | 3,929 | 490 | 0% (0) | 20% | $893,599 |
| 2021 | 3,727 | 429 | 0% (0) | 22% | $839,934 |
| 2020 | 3,666 | 415 | 0% (0) | 25% | $770,530 |
| 2019 | 3,412 | 391 | None | 25% | $631,644 |
| 2018 | 2,987 | 331 | 0% (0) | 25% | $511,506 |
| 2017 | 2,728 | 277 | 0% (0) | 29% | $413,741 |
| 2016 | 2,453 | 250 | None | 32% | $380,280 |
| 2015 | 2,483 | 235 | 0% (0) | 32% | $299,694 |
| 2014 | 2,318 | 221 | None | 32% | $252,484 |
| 2013 | 2,185 | 195 | None | 32% | $203,713 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Eliquis | 555 | $672,947 | $1,213 |
| Xarelto | 103 | $123,082 | $1,195 |
| Multaq | 36 | $67,163 | $1,866 |
| Jardiance | 47 | $46,336 | $986 |
| Entresto | 39 | $44,209 | $1,134 |
| Repatha Sureclick | 19 | $27,116 | $1,427 |
| Dofetilide | 45 | $23,410 | $520 |
| Praluent | 17 | $12,084 | $711 |
| Metoprolol | 355 | $7,209 | $20 |
| Diltiazem 24hr Er (Cd) | 128 | $6,306 | $49 |
| Atorvastatin | 516 | $5,996 | $12 |
| Losartan | 253 | $4,010 | $16 |
| Rosuvastatin | 189 | $3,465 | $18 |
| Flecainide Acetate | 76 | $3,452 | $45 |
| Ezetimibe | 52 | $2,928 | $56 |
| Valsartan | 64 | $2,693 | $42 |
| Amlodipine Besylate | 295 | $2,545 | $9 |
| Spironolactone-Hctz | 47 | $2,263 | $48 |
| Carvedilol | 130 | $2,169 | $17 |
| Potassium Chloride | 60 | $2,143 | $36 |
| Lisinopril | 171 | $1,947 | $11 |
| Spironolactone | 133 | $1,595 | $12 |
| Valsartan-Hydrochlorothiazide | 21 | $1,254 | $60 |
| Toprol Xl | 12 | $1,066 | $89 |
| Furosemide | 145 | $977 | $7 |
| Hydrochlorothiazide | 124 | $940 | $8 |
| Eplerenone | 14 | $766 | $55 |
| Olmesartan Medoxomil | 21 | $736 | $35 |
| Irbesartan | 16 | $670 | $42 |
| Sotalol | 28 | $670 | $24 |
| Metoprolol | 67 | $637 | $10 |
| Clopidogrel | 42 | $569 | $14 |
| Telmisartan | 11 | $450 | $41 |
| Sotalol Af | 24 | $437 | $18 |
| Benazepril | 19 | $380 | $20 |
| Simvastatin | 38 | $370 | $10 |
| Torsemide | 13 | $369 | $28 |
| Diltiazem 24hr Er | 18 | $356 | $20 |
| Warfarin | 19 | $272 | $14 |
| Atenolol | 19 | $165 | $9 |
| Lisinopril-Hydrochlorothiazide | 13 | $101 | $8 |
| Ramipril | 12 | $99 | $8 |
| Enalapril Maleate | 11 | $93 | $8 |
2022: 43 drugs
| Eliquis | 494 | $540,570 | $1,094 |
| Xarelto | 91 | $103,237 | $1,134 |
| Multaq | 37 | $56,550 | $1,528 |
| Entresto | 28 | $30,652 | $1,095 |
| Dofetilide | 42 | $19,658 | $468 |
| Repatha Sureclick | 18 | $18,793 | $1,044 |
| Diltiazem 24hr Er (Cd) | 136 | $6,623 | $49 |
| Metoprolol | 324 | $6,311 | $19 |
| Rosuvastatin | 156 | $5,658 | $36 |
| Atorvastatin | 410 | $5,535 | $14 |
| Losartan | 237 | $4,032 | $17 |
| Flecainide Acetate | 47 | $3,405 | $72 |
| Valsartan | 62 | $3,282 | $53 |
| Carvedilol | 137 | $2,788 | $20 |
| Amlodipine Besylate | 286 | $2,072 | $7 |
| Potassium Chloride | 59 | $1,927 | $33 |
| Lisinopril | 202 | $1,895 | $9 |
| Dilt-Xr | 15 | $1,763 | $118 |
| Spironolactone | 118 | $1,745 | $15 |
| Ezetimibe | 26 | $1,689 | $65 |
| Valsartan-Hydrochlorothiazide | 16 | $1,343 | $84 |
| Spironolactone-Hctz | 29 | $1,241 | $43 |
| Irbesartan | 34 | $1,134 | $33 |
| Hydrochlorothiazide | 130 | $1,117 | $9 |
| Furosemide | 146 | $1,045 | $7 |
| Telmisartan | 20 | $998 | $50 |
| Sotalol Af | 27 | $852 | $32 |
| Metoprolol | 64 | $734 | $11 |
| Olmesartan Medoxomil | 25 | $684 | $27 |
| Eplerenone | 13 | $602 | $46 |
| Torsemide | 12 | $587 | $49 |
| Digoxin | 25 | $500 | $20 |
| Clopidogrel | 21 | $392 | $19 |
| Warfarin | 24 | $388 | $16 |
| Simvastatin | 43 | $348 | $8 |
| Sotalol | 26 | $343 | $13 |
| Diltiazem 24hr Er | 12 | $334 | $28 |
| Quinapril | 11 | $285 | $26 |
| Pravastatin | 12 | $214 | $18 |
| Atenolol | 28 | $176 | $6 |
| Benazepril | 12 | $168 | $14 |
| Lisinopril-Hydrochlorothiazide | 18 | $122 | $7 |
| Ramipril | 12 | $104 | $9 |
2021: 44 drugs
| Eliquis | 490 | $520,611 | $1,062 |
| Xarelto | 82 | $93,628 | $1,142 |
| Multaq | 31 | $36,385 | $1,174 |
| Repatha Sureclick | 16 | $19,000 | $1,188 |
| Dofetilide | 37 | $17,347 | $469 |
| Entresto | 17 | $15,968 | $939 |
| Pradaxa | 13 | $11,639 | $895 |
| Diltiazem 24hr Er (Cd) | 151 | $7,436 | $49 |
| Metoprolol | 313 | $6,857 | $22 |
| Bystolic | 13 | $6,360 | $489 |
| Atorvastatin | 363 | $5,237 | $14 |
| Vascepa | 12 | $5,107 | $426 |
| Losartan | 232 | $4,634 | $20 |
| Valsartan | 62 | $3,943 | $64 |
| Rosuvastatin | 129 | $3,821 | $30 |
| Mexiletine | 12 | $3,287 | $274 |
| Flecainide Acetate | 29 | $3,219 | $111 |
| Ezetimibe | 44 | $2,705 | $61 |
| Carvedilol | 136 | $2,453 | $18 |
| Potassium Chloride | 74 | $2,436 | $33 |
| Amlodipine Besylate | 262 | $2,249 | $9 |
| Dilt-Xr | 19 | $1,975 | $104 |
| Lisinopril | 185 | $1,653 | $9 |
| Spironolactone | 93 | $1,300 | $14 |
| Irbesartan | 28 | $1,116 | $40 |
| Olmesartan Medoxomil | 21 | $1,089 | $52 |
| Hydrochlorothiazide | 124 | $985 | $8 |
| Cartia Xt | 11 | $971 | $88 |
| Valsartan-Hydrochlorothiazide | 17 | $952 | $56 |
| Furosemide | 144 | $901 | $6 |
| Digoxin | 21 | $740 | $35 |
| Spironolactone-Hctz | 17 | $704 | $41 |
| Warfarin | 31 | $671 | $22 |
| Metoprolol | 56 | $667 | $12 |
| Torsemide | 13 | $627 | $48 |
| Diltiazem 24hr Er | 13 | $583 | $45 |
| Simvastatin | 40 | $561 | $14 |
| Sotalol Af | 12 | $554 | $46 |
| Sotalol | 26 | $330 | $13 |
| Clonidine | 11 | $294 | $27 |
| Pravastatin | 14 | $271 | $19 |
| Atenolol | 22 | $248 | $11 |
| Clopidogrel | 25 | $222 | $9 |
| Lisinopril-Hydrochlorothiazide | 16 | $61 | $4 |
2020: 43 drugs
| Eliquis | 503 | $437,527 | $870 |
| Xarelto | 86 | $90,668 | $1,054 |
| Multaq | 46 | $53,258 | $1,158 |
| Dofetilide | 42 | $17,754 | $423 |
| Pradaxa | 18 | $16,133 | $896 |
| Repatha Sureclick | 18 | $14,135 | $785 |
| Entresto | 16 | $13,509 | $844 |
| Diltiazem 24hr Er (Cd) | 120 | $9,488 | $79 |
| Bystolic | 20 | $8,899 | $445 |
| Metoprolol | 324 | $8,865 | $27 |
| Valsartan | 79 | $5,283 | $67 |
| Losartan | 261 | $5,265 | $20 |
| Atorvastatin | 303 | $5,148 | $17 |
| Propafenone Hcl Er | 14 | $4,949 | $353 |
| Flecainide Acetate | 44 | $3,876 | $88 |
| Dilt-Xr | 34 | $2,912 | $86 |
| Potassium Chloride | 70 | $2,508 | $36 |
| Prasugrel | 11 | $2,378 | $216 |
| Rosuvastatin | 81 | $2,119 | $26 |
| Amlodipine Besylate | 236 | $2,002 | $8 |
| Carvedilol | 106 | $1,963 | $19 |
| Ezetimibe | 29 | $1,702 | $59 |
| Lisinopril | 151 | $1,575 | $10 |
| Digoxin | 30 | $1,501 | $50 |
| Cartia Xt | 25 | $1,380 | $55 |
| Hydrochlorothiazide | 119 | $1,100 | $9 |
| Furosemide | 115 | $1,016 | $9 |
| Irbesartan | 30 | $1,008 | $34 |
| Spironolactone | 88 | $1,007 | $11 |
| Spironolactone-Hctz | 21 | $1,005 | $48 |
| Olmesartan Medoxomil | 30 | $997 | $33 |
| Valsartan-Hydrochlorothiazide | 20 | $886 | $44 |
| Diltiazem 24hr Er | 13 | $842 | $65 |
| Clopidogrel | 37 | $735 | $20 |
| Pravastatin | 23 | $724 | $31 |
| Atenolol | 38 | $640 | $17 |
| Warfarin | 28 | $595 | $21 |
| Simvastatin | 51 | $563 | $11 |
| Metoprolol | 47 | $496 | $11 |
| Sotalol | 17 | $428 | $25 |
| Amiodarone | 16 | $306 | $19 |
| Lovastatin | 11 | $220 | $20 |
| Omeprazole | 12 | $211 | $18 |
2019: 45 drugs
| Eliquis | 429 | $317,658 | $740 |
| Xarelto | 111 | $89,409 | $805 |
| Multaq | 45 | $39,199 | $871 |
| Dofetilide | 39 | $25,222 | $647 |
| Pradaxa | 27 | $19,950 | $739 |
| Repatha Sureclick | 27 | $19,407 | $719 |
| Entresto | 19 | $11,990 | $631 |
| Metoprolol | 351 | $10,411 | $30 |
| Propafenone Hcl Er | 14 | $7,342 | $524 |
| Diltiazem 24hr Er (Cd) | 94 | $7,216 | $77 |
| Bystolic | 12 | $5,141 | $428 |
| Flecainide Acetate | 45 | $4,115 | $91 |
| Losartan | 249 | $4,019 | $16 |
| Atorvastatin | 210 | $3,858 | $18 |
| Potassium Chloride | 72 | $2,827 | $39 |
| Cartia Xt | 37 | $2,753 | $74 |
| Amlodipine Besylate | 250 | $2,607 | $10 |
| Valsartan | 66 | $2,121 | $32 |
| Ezetimibe | 28 | $2,096 | $75 |
| Lisinopril | 189 | $2,001 | $11 |
| Rosuvastatin | 45 | $1,871 | $42 |
| Dilt-Xr | 18 | $1,849 | $103 |
| Carvedilol | 93 | $1,416 | $15 |
| Irbesartan | 30 | $1,373 | $46 |
| Olmesartan Medoxomil | 21 | $1,092 | $52 |
| Spironolactone | 92 | $1,070 | $12 |
| Digoxin | 24 | $1,066 | $44 |
| Hydrochlorothiazide | 105 | $1,026 | $10 |
| Simvastatin | 74 | $993 | $13 |
| Furosemide | 96 | $786 | $8 |
| Pravastatin | 30 | $749 | $25 |
| Spironolactone-Hctz | 11 | $663 | $60 |
| Valsartan-Hydrochlorothiazide | 12 | $553 | $46 |
| Verapamil Er | 11 | $486 | $44 |
| Warfarin | 22 | $473 | $21 |
| Atenolol | 41 | $405 | $10 |
| Isosorbide Mononitrate Er | 14 | $396 | $28 |
| Metoprolol | 31 | $348 | $11 |
| Lovastatin | 15 | $302 | $20 |
| Clopidogrel | 18 | $295 | $16 |
| Ramipril | 13 | $290 | $22 |
| Sotalol | 17 | $282 | $17 |
| Omeprazole | 13 | $199 | $15 |
| Losartan-Hydrochlorothiazide | 13 | $191 | $15 |
| Levothyroxine | 14 | $108 | $8 |
2018: 46 drugs
| Eliquis | 329 | $236,804 | $720 |
| Xarelto | 127 | $88,650 | $698 |
| Multaq | 44 | $37,956 | $863 |
| Pradaxa | 27 | $21,407 | $793 |
| Dofetilide | 30 | $15,664 | $522 |
| Metoprolol | 269 | $9,718 | $36 |
| Entresto | 19 | $9,241 | $486 |
| Propafenone Hcl Er | 27 | $8,889 | $329 |
| Diltiazem 24hr Er (Cd) | 62 | $3,636 | $59 |
| Ezetimibe | 18 | $3,594 | $200 |
| Flecainide Acetate | 30 | $3,325 | $111 |
| Crestor | 12 | $3,129 | $261 |
| Atorvastatin | 145 | $3,058 | $21 |
| Losartan | 203 | $2,570 | $13 |
| Amlodipine Besylate | 246 | $2,412 | $10 |
| Cartia Xt | 49 | $2,300 | $47 |
| Plavix | 11 | $2,139 | $194 |
| Lisinopril | 222 | $2,035 | $9 |
| Valsartan | 58 | $1,766 | $30 |
| Dilt-Xr | 26 | $1,738 | $67 |
| Potassium Chloride | 55 | $1,475 | $27 |
| Rosuvastatin | 34 | $1,456 | $43 |
| Carvedilol | 91 | $1,146 | $13 |
| Spironolactone | 81 | $1,042 | $13 |
| Simvastatin | 83 | $993 | $12 |
| Digoxin | 18 | $966 | $54 |
| Spironolactone-Hctz | 17 | $908 | $53 |
| Olmesartan Medoxomil | 19 | $839 | $44 |
| Valsartan-Hydrochlorothiazide | 17 | $723 | $43 |
| Furosemide | 97 | $692 | $7 |
| Irbesartan | 19 | $595 | $31 |
| Warfarin | 27 | $543 | $20 |
| Isosorbide Mononitrate Er | 15 | $488 | $33 |
| Hydrochlorothiazide | 73 | $469 | $6 |
| Diltiazem 24hr Er | 11 | $357 | $32 |
| Pravastatin | 11 | $349 | $32 |
| Atenolol | 26 | $344 | $13 |
| Clonidine | 20 | $342 | $17 |
| Ramipril | 16 | $314 | $20 |
| Sotalol | 19 | $308 | $16 |
| Tamsulosin | 18 | $251 | $14 |
| Metoprolol | 20 | $250 | $12 |
| Omeprazole | 13 | $236 | $18 |
| Benazepril | 19 | $210 | $11 |
| Lovastatin | 12 | $183 | $15 |
| Levothyroxine | 12 | $112 | $9 |
2017: 40 drugs
| Eliquis | 286 | $162,132 | $567 |
| Xarelto | 120 | $69,414 | $578 |
| Pradaxa | 34 | $22,063 | $649 |
| Dofetilide | 37 | $21,727 | $587 |
| Multaq | 25 | $17,766 | $711 |
| Propafenone Hcl Er | 29 | $13,921 | $480 |
| Zetia | 26 | $13,387 | $515 |
| Metoprolol | 205 | $6,712 | $33 |
| Entresto | 12 | $5,017 | $418 |
| Diltiazem 24hr Er | 71 | $4,481 | $63 |
| Flecainide Acetate | 33 | $3,438 | $104 |
| Atorvastatin | 132 | $2,408 | $18 |
| Losartan | 195 | $2,264 | $12 |
| Valsartan | 59 | $1,995 | $34 |
| Lisinopril | 214 | $1,818 | $8 |
| Propafenone | 14 | $1,746 | $125 |
| Amlodipine Besylate | 229 | $1,655 | $7 |
| Rosuvastatin | 41 | $1,552 | $38 |
| Ezetimibe | 11 | $1,129 | $103 |
| Cartia Xt | 25 | $993 | $40 |
| Potassium Chloride | 41 | $988 | $24 |
| Dilt-Xr | 16 | $907 | $57 |
| Spironolactone | 50 | $804 | $16 |
| Carvedilol | 96 | $763 | $8 |
| Simvastatin | 75 | $742 | $10 |
| Valsartan-Hydrochlorothiazide | 13 | $699 | $54 |
| Digoxin | 16 | $636 | $40 |
| Irbesartan | 21 | $501 | $24 |
| Furosemide | 102 | $453 | $4 |
| Sotalol | 32 | $417 | $13 |
| Diltiazem 24hr Cd | 13 | $416 | $32 |
| Isosorbide Mononitrate Er | 11 | $363 | $33 |
| Warfarin | 16 | $331 | $21 |
| Hydrochlorothiazide | 51 | $309 | $6 |
| Atenolol | 44 | $284 | $6 |
| Lovastatin | 19 | $210 | $11 |
| Benazepril | 15 | $132 | $9 |
| Lisinopril-Hydrochlorothiazide | 14 | $125 | $9 |
| Metoprolol | 12 | $103 | $9 |
| Tamsulosin | 12 | $52 | $4 |
2016: 41 drugs
| Eliquis | 284 | $133,096 | $469 |
| Xarelto | 80 | $44,477 | $556 |
| Pradaxa | 77 | $41,307 | $536 |
| Multaq | 17 | $16,549 | $973 |
| Propafenone Hcl Er | 40 | $15,524 | $388 |
| Zetia | 17 | $8,696 | $512 |
| Dofetilide | 15 | $8,557 | $570 |
| Tikosyn | 13 | $7,506 | $577 |
| Crestor | 15 | $7,186 | $479 |
| Metoprolol | 224 | $6,528 | $29 |
| Coreg | 17 | $6,435 | $379 |
| Bystolic | 16 | $4,858 | $304 |
| Diltiazem 24hr Er | 44 | $4,649 | $106 |
| Plavix | 13 | $2,763 | $213 |
| Diltiazem 24hr Cd | 28 | $2,513 | $90 |
| Atorvastatin | 101 | $1,876 | $19 |
| Losartan | 168 | $1,578 | $9 |
| Valsartan | 41 | $1,566 | $38 |
| Cartia Xt | 24 | $1,557 | $65 |
| Lisinopril | 186 | $1,555 | $8 |
| Flecainide Acetate | 41 | $1,443 | $35 |
| Amlodipine Besylate | 211 | $1,352 | $6 |
| Potassium Chloride | 36 | $1,063 | $30 |
| Spironolactone-Hctz | 16 | $1,016 | $64 |
| Carvedilol | 74 | $852 | $12 |
| Simvastatin | 91 | $826 | $9 |
| Valsartan-Hydrochlorothiazide | 29 | $672 | $23 |
| Verapamil Er | 12 | $553 | $46 |
| Spironolactone | 45 | $542 | $12 |
| Furosemide | 69 | $471 | $7 |
| Diltiazem Er | 12 | $400 | $33 |
| Pravastatin | 11 | $349 | $32 |
| Lovastatin | 22 | $316 | $14 |
| Bisoprolol-Hydrochlorothiazide | 12 | $284 | $24 |
| Sotalol | 11 | $225 | $20 |
| Benazepril | 19 | $191 | $10 |
| Hydrochlorothiazide | 29 | $178 | $6 |
| Warfarin | 18 | $162 | $9 |
| Metoprolol | 22 | $125 | $6 |
| Atenolol | 26 | $101 | $4 |
| Lisinopril-Hydrochlorothiazide | 13 | $62 | $5 |
2015: 45 drugs
| Eliquis | 200 | $75,784 | $379 |
| Pradaxa | 109 | $45,898 | $421 |
| Xarelto | 73 | $32,831 | $450 |
| Propafenone Hcl Er | 53 | $19,070 | $360 |
| Multaq | 18 | $16,997 | $944 |
| Tikosyn | 30 | $13,513 | $450 |
| Zetia | 16 | $8,461 | $529 |
| Metoprolol | 189 | $6,413 | $34 |
| Bystolic | 22 | $3,902 | $177 |
| Diovan | 14 | $3,717 | $265 |
| Diltiazem 24hr Er | 25 | $3,242 | $130 |
| Valsartan | 29 | $2,919 | $101 |
| Telmisartan-Hydrochlorothiazid | 12 | $2,440 | $203 |
| Atorvastatin | 109 | $2,172 | $20 |
| Diltiazem 24hr Cd | 45 | $1,547 | $34 |
| Valsartan-Hydrochlorothiazide | 34 | $1,288 | $38 |
| Cartia Xt | 27 | $1,244 | $46 |
| Lisinopril | 226 | $1,226 | $5 |
| Dilt-Xr | 21 | $1,207 | $57 |
| Amlodipine Besylate | 183 | $1,143 | $6 |
| Carvedilol | 128 | $1,088 | $8 |
| Flecainide Acetate | 28 | $1,055 | $38 |
| Diltiazem Er | 28 | $1,008 | $36 |
| Losartan | 129 | $995 | $8 |
| Potassium Chloride | 32 | $879 | $27 |
| Propranolol Hcl Er | 12 | $872 | $73 |
| Toprol Xl | 16 | $578 | $36 |
| Simvastatin | 95 | $568 | $6 |
| Digox | 18 | $558 | $31 |
| Pravastatin | 20 | $486 | $24 |
| Propafenone | 13 | $473 | $36 |
| Spironolactone | 39 | $442 | $11 |
| Clopidogrel | 25 | $366 | $15 |
| Warfarin | 25 | $365 | $15 |
| Furosemide | 57 | $327 | $6 |
| Atenolol | 25 | $312 | $12 |
| Benazepril-Hydrochlorothiazide | 12 | $303 | $25 |
| Hydrochlorothiazide | 29 | $272 | $9 |
| Lovastatin | 31 | $247 | $8 |
| Nadolol | 12 | $235 | $20 |
| Isosorbide Mononitrate Er | 13 | $148 | $11 |
| Sotalol | 16 | $136 | $8 |
| Benazepril | 15 | $97 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $72 | $7 |
| Bisoprolol-Hydrochlorothiazide | 11 | $65 | $6 |
2014: 41 drugs
| Eliquis | 119 | $46,178 | $388 |
| Pradaxa | 110 | $44,653 | $406 |
| Xarelto | 77 | $28,293 | $367 |
| Propafenone Hcl Er | 48 | $19,063 | $397 |
| Diovan | 54 | $12,696 | $235 |
| Tikosyn | 36 | $12,218 | $339 |
| Multaq | 12 | $9,984 | $832 |
| Metoprolol | 178 | $6,929 | $39 |
| Zetia | 20 | $6,638 | $332 |
| Diltiazem 24hr Er | 23 | $3,583 | $156 |
| Bystolic | 21 | $3,466 | $165 |
| Micardis Hct | 13 | $3,194 | $246 |
| Atorvastatin | 97 | $2,090 | $22 |
| Diltiazem Er | 48 | $1,979 | $41 |
| Digox | 49 | $1,769 | $36 |
| Cartia Xt | 30 | $1,464 | $49 |
| Valsartan-Hydrochlorothiazide | 27 | $1,454 | $54 |
| Amlodipine Besylate | 186 | $1,389 | $7 |
| Telmisartan-Hydrochlorothiazid | 11 | $1,313 | $119 |
| Propafenone | 19 | $1,311 | $69 |
| Lisinopril | 210 | $1,306 | $6 |
| Carvedilol | 101 | $1,123 | $11 |
| Losartan | 83 | $1,045 | $13 |
| Simvastatin | 104 | $1,007 | $10 |
| Diltiazem 24hr Cd | 23 | $971 | $42 |
| Potassium Chloride | 24 | $916 | $38 |
| Propranolol Hcl Er | 16 | $801 | $50 |
| Spironolactone | 71 | $774 | $11 |
| Hydrochlorothiazide | 42 | $595 | $14 |
| Flecainide Acetate | 19 | $561 | $30 |
| Verapamil Er | 20 | $477 | $24 |
| Torsemide | 13 | $466 | $36 |
| Warfarin | 37 | $437 | $12 |
| Pravastatin | 14 | $307 | $22 |
| Furosemide | 58 | $282 | $5 |
| Benazepril-Hydrochlorothiazide | 13 | $278 | $21 |
| Clopidogrel | 16 | $258 | $16 |
| Lovastatin | 20 | $210 | $11 |
| Benazepril | 22 | $195 | $9 |
| Sotalol | 15 | $155 | $10 |
| Atenolol | 25 | $147 | $6 |
2013: 46 drugs
| Pradaxa | 135 | $49,397 | $366 |
| Propafenone | 65 | $22,272 | $343 |
| Xarelto | 60 | $19,181 | $320 |
| Multaq | 11 | $8,865 | $806 |
| Diovan | 46 | $8,736 | $190 |
| Eliquis | 24 | $8,723 | $363 |
| Tikosyn | 22 | $7,031 | $320 |
| Metoprolol | 154 | $6,767 | $44 |
| Rythmol Sr | 12 | $5,758 | $480 |
| Micardis Hct | 20 | $4,772 | $239 |
| Zetia | 14 | $3,715 | $265 |
| Atorvastatin | 112 | $3,591 | $32 |
| Coreg Cr | 13 | $2,811 | $216 |
| Bystolic | 15 | $2,490 | $166 |
| Diltiazem Er | 56 | $2,332 | $42 |
| Cartia Xt | 45 | $2,252 | $50 |
| Carvedilol | 125 | $1,576 | $13 |
| Clopidogrel | 39 | $1,498 | $38 |
| Lisinopril | 186 | $1,450 | $8 |
| Potassium Chloride | 27 | $1,258 | $47 |
| Amlodipine Besylate | 117 | $1,177 | $10 |
| Simvastatin | 89 | $1,034 | $12 |
| Diltiazem 24hr Cd | 24 | $1,031 | $43 |
| Valsartan-Hydrochlorothiazide | 11 | $910 | $83 |
| Toprol Xl | 18 | $846 | $47 |
| Losartan | 49 | $846 | $17 |
| Diltiazem 24hr Er | 22 | $843 | $38 |
| Felodipine Er | 13 | $758 | $58 |
| Hydrochlorothiazide | 42 | $638 | $15 |
| Spironolactone | 66 | $618 | $9 |
| Flecainide Acetate | 20 | $545 | $27 |
| Digox | 52 | $500 | $10 |
| Propranolol | 21 | $481 | $23 |
| Furosemide | 91 | $354 | $4 |
| Warfarin | 13 | $337 | $26 |
| Lovastatin | 26 | $238 | $9 |
| Amiodarone | 16 | $228 | $14 |
| Atenolol | 25 | $217 | $9 |
| Spironolactone-Hctz | 13 | $202 | $16 |
| Omeprazole | 12 | $171 | $14 |
| Benazepril | 12 | $154 | $13 |
| Levothyroxine | 14 | $145 | $10 |
| Allopurinol | 11 | $72 | $7 |
| Zolpidem | 11 | $54 | $5 |
| Levoxyl | 12 | $49 | $4 |
| Prednisone | 11 | $33 | $3 |
Money from drug and device companies
$46,489 in 2025
| 2025 | 7 | 91 | $35,013 | $46,489 |
| 2024 | 5 | 96 | $22,688 | $32,482 |
| 2023 | 7 | 70 | $12,564 | $20,875 |
| 2022 | 8 | 17 | None | $1,461 |
| 2021 | 3 | 4 | None | $272 |
| 2020 | 11 | 18 | None | $352 |
| 2019 | 14 | 107 | $250 | $3,028 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aurora Ev-Icd Mri Surescan | $41,576 | 61 payments
|
| Abbott Laboratories | Tacticath Ablation Catheter, Sensor Enabled | $3,502 | 14 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $674 | 7 payments
|
| Boston Scientific | Farapulse | $364 | 6 payments
|
| Biosense Webster | Carto 3 | $144 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $131 | 1 payment
|
See all 91 published payments
| Medtronic | Travel · 2025-12-17 | None | $619 |
| Medtronic | Consulting · 2025-12-11 | None | $1,000 |
| Medtronic | Paid to speak or teach · 2025-12-03 | Aurora Ev-Icd Mri Surescan | $3,200 |
| W. L. Gore & Associates | Meals · 2025-12-02 | Excluder Conformable Aaa Endoprosthesis With Active Control | $98 |
| Medtronic | Meals · 2025-11-10 | Aurora Ev-Icd Mri Surescan | $22 |
| Abbott Laboratories | Meals · 2025-10-27 | Agilis | $29 |
| Medtronic | Paid to speak or teach · 2025-10-20 | None | $6,000 |
| Medtronic | Consulting · 2025-10-15 | None | $1,000 |
| Medtronic | Meals · 2025-10-10 | Affera Mapping System | $50 |
| Medtronic | Meals · 2025-09-29 | Aurora Ev-Icd Mri Surescan | $132 |
| Boston Scientific | Meals · 2025-09-25 | Farapulse | $35 |
| Medtronic | Travel · 2025-09-25 | None | $278 |
| Medtronic | Travel · 2025-09-25 | None | $50 |
| Medtronic | Meals · 2025-09-25 | Aurora Ev-Icd Mri Surescan | $114 |
| Medtronic | Travel · 2025-09-24 | None | $354 |
| Medtronic | Travel · 2025-09-24 | None | $278 |
| Medtronic | Travel · 2025-09-24 | None | $50 |
| Medtronic | Paid to speak or teach · 2025-09-22 | None | $3,500 |
| AtriCure | Meals · 2025-09-18 | Synergy Ablation System | $186 |
| Medtronic | Meals · 2025-09-10 | Aurora Ev-Icd Mri Surescan | $175 |
| Medtronic | Travel · 2025-08-15 | None | $512 |
| Biosense Webster | Meals · 2025-07-30 | Carto 3 | $144 |
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-07-17 | Epi-Sense Guided Coagulation System With Visitrax | $37 |
| Abbott Laboratories | Meals · 2025-07-17 | Viewmate | $29 |
| Abbott Laboratories | Meals · 2025-06-27 | Agilis | $25 |
| Abbott Laboratories | Meals · 2025-06-11 | Ensite | $174 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| Abbott Laboratories | Meals · 2025-05-22 | Tacticath Ablation Catheter, Sensor Enabled | $33 |
| Abbott Laboratories | Meals · 2025-05-22 | Tacticath Ablation Catheter, Sensor Enabled | $2 |
| Medtronic | Meals · 2025-05-21 | Aurora Ev-Icd Mri Surescan | $161 |
| Abbott Laboratories | Consulting · 2025-05-20 | Tacticath Ablation Catheter, Sensor Enabled | $2,500 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $36 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $11 |
| Medtronic | Meals · 2025-05-14 | Aurora Ev-Icd Mri Surescan | $25 |
| Boston Scientific | Meals · 2025-05-09 | Farapulse | $37 |
| Abbott Laboratories | Travel · 2025-05-09 | Tacticath Ablation Catheter, Sensor Enabled | $205 |
| Abbott Laboratories | Travel · 2025-05-09 | Tacticath Ablation Catheter, Sensor Enabled | $205 |
| Abbott Laboratories | Travel · 2025-05-09 | Tacticath Ablation Catheter, Sensor Enabled | $9 |
| Medtronic | Paid to speak or teach · 2025-05-06 | None | $9,750 |
| Medtronic | Travel · 2025-05-05 | Evera Mri Xt Dr Surescan | $115 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-01 | Camzyos | $131 |
| Abbott Laboratories | Meals · 2025-05-01 | Agilis | $24 |
| Boston Scientific | Meals · 2025-04-29 | Farapulse | $29 |
| Medtronic | Meals · 2025-04-29 | Aurora Ev-Icd Mri Surescan | $7 |
| Medtronic | Meals · 2025-04-28 | Aurora Ev-Icd Mri Surescan | $48 |
| Medtronic | Meals · 2025-04-28 | Evera Mri Xt Dr Surescan | $62 |
| Medtronic | Meals · 2025-04-28 | Evera Mri Xt Dr Surescan | $26 |
| Medtronic | Travel · 2025-04-27 | Evera Mri Xt Dr Surescan | $229 |
| Medtronic | Travel · 2025-04-27 | Evera Mri Xt Dr Surescan | $26 |
| Boston Scientific | Meals · 2025-04-24 | General - Therapies | $75 |
| Medtronic | Consulting · 2025-04-17 | None | $5,563 |
| Boston Scientific | Meals · 2025-04-16 | Farapulse | $137 |
| Medtronic | Travel · 2025-04-14 | None | $100 |
| Medtronic | Meals · 2025-04-14 | None | $7 |
| Medtronic | Meals · 2025-04-14 | None | $9 |
| Medtronic | Meals · 2025-04-14 | None | $41 |
| Medtronic | Travel · 2025-04-14 | None | $55 |
| Medtronic | Meals · 2025-04-14 | None | $34 |
| Medtronic | Travel · 2025-04-14 | None | $137 |
| Medtronic | Meals · 2025-04-10 | None | $175 |
| Medtronic | Travel · 2025-04-10 | None | $229 |
| Medtronic | Travel · 2025-04-10 | None | $34 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
| Abbott Laboratories | Meals · 2025-03-17 | Ensite | $214 |
| Boston Scientific | Meals · 2025-03-12 | Watchman Flx | $51 |
| Abbott Laboratories | Meals · 2025-03-11 | Perclose Prostyle | $24 |
| Medtronic | Meals · 2025-03-04 | None | $6 |
| Medtronic | Meals · 2025-03-04 | Aurora Ev-Icd Mri Surescan | $169 |
| Medtronic | Paid to speak or teach · 2025-02-20 | None | $2,500 |
| Medtronic | Travel · 2025-02-12 | Micra | $826 |
| Medtronic | Meals · 2025-02-10 | Affera Mapping System | $100 |
| Medtronic | Travel · 2025-02-03 | None | $667 |
| Medtronic | Travel · 2025-02-03 | None | $35 |
| Medtronic | Meals · 2025-02-02 | None | $151 |
| Medtronic | Meals · 2025-02-02 | None | $150 |
| Medtronic | Meals · 2025-02-02 | None | $71 |
| Medtronic | Meals · 2025-02-01 | None | $228 |
| Medtronic | Meals · 2025-02-01 | None | $163 |
| Medtronic | Meals · 2025-02-01 | None | $207 |
| Medtronic | Meals · 2025-02-01 | None | $156 |
| Medtronic | Travel · 2025-02-01 | None | $349 |
| Medtronic | Travel · 2025-02-01 | None | $78 |
| Medtronic | Travel · 2025-01-31 | None | $349 |
| Medtronic | Travel · 2025-01-31 | None | $76 |
| Medtronic | Meals · 2025-01-31 | None | $209 |
| Abbott Laboratories | Meals · 2025-01-21 | Perclose Prostyle | $29 |
| Medtronic | Travel · 2025-01-20 | None | $276 |
| Medtronic | Travel · 2025-01-20 | None | $309 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $32,482
| Medtronic | Evera Mri Xt Dr Surescan | $31,284 | 79 payments
|
| Boston Scientific | Rhythmia Mapping System | $655 | 9 payments
|
| Abbott Laboratories | Ensite Precision | $209 | 6 payments
|
| Impulse Dynamics (USA) | Optimizer | $185 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
2023: $20,875
| Medtronic | Evera Mri Xt Dr Surescan | $18,740 | 51 payments
|
| Boston Scientific | Rhythmia Mapping System | $737 | 9 payments
|
| Abbott Laboratories | Ensite | $714 | 5 payments
|
| Ablacon | None | $241 | 1 payment
|
| Biosense Webster | Carto 3 | $193 | 2 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $150 | 1 payment
|
| Biotronik | Edora 8 Dr-T | $100 | 1 payment
|
2022: $1,461
| Abbott Laboratories | Ensite Precision | $414 | 3 payments
|
| Boston Scientific | Rhythmia Mapping System | $369 | 5 payments
|
| Impulse Dynamics (USA) | Optimizer | $217 | 1 payment
|
| Medtronic | Cobalt Dr Mri Surescan | $145 | 2 payments
|
| Biotronik | None | $115 | 1 payment
|
| Ablacon | None | $90 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $85 | 3 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $28 | 1 payment
|
2021: $272
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $207 | 2 payments
|
| Medtronic | Micra | $46 | 1 payment
|
| Shockwave Medical | Vascular Lithotripsy | $20 | 1 payment
|
2020: $352
| Pfizer | Eliquis | $57 | 3 payments
|
| Amgen | Repatha | $53 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $43 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $40 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $39 | 2 payments
|
| Abbott Laboratories | Confirm Rx | $34 | 1 payment
|
| Medtronic Vascular | Claria Mri | $19 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
| Biosense Webster | Carto 3 System | $18 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
2019: $3,028
| Medtronic Vascular | Azure | $1,069 | 15 payments
|
| Amgen | Corlanor | $418 | 15 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $364 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $233 | 16 payments
|
| Sanofi-Aventis U.S. | Praluent | $218 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $171 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $147 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $114 | 13 payments
|
| Regeneron Healthcare Solutions | Praluent | $87 | 3 payments
|
| Pfizer | Eliquis | $84 | 4 payments
|
| Medtronic USA | Reveal Linq | $33 | 1 payment
|
| Arbor Pharmaceuticals | Edarbyclor | $33 | 2 payments
|
| Boston Scientific | Watchman | $33 | 2 payments
|
| Lundbeck | Northera | $24 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Medtronic, Inc. · Ev Icd Pivotal · 2021 | Their institution | $42,531 |
| Boston Scientific Corporation · Avant Guard · 2024 | Their institution | $18,500 |
| Medtronic, Inc. · Ev Icd Pivotal · 2024 | Their institution | $18,059 |
| Medtronic Vascular, Inc. · Ev Icd Pivotal · 2020 | Their institution | $14,000 |
| Medtronic, Inc. · Ev Icd Pivotal · 2023 | Their institution | $13,840 |
| Medtronic, Inc. · Ev Icd Pivotal · 2022 | Their institution | $11,618 |
| Medtronic, Inc. · Ev Icd CA · 2024 | Their institution | $9,628 |
| Medtronic, Inc. · Ev Icd CA · 2023 | Their institution | $7,758 |
| Medtronic, Inc. · Diamond-Af II Tp01071 · 2022 | Their institution | $4,600 |
| Medtronic, Inc. · Diamond-Af II Tp01071 · 2023 | Their institution | $4,000 |
| Medtronic Vascular, Inc. · Ev Icd Pivotal · 2020 | This clinician | $3,500 |
| Medtronic, Inc. · Psr-Cvg · 2024 | This clinician | $3,375 |
| Medtronic, Inc. · Psr-Cvg · 2025 | This clinician | $2,313 |
Professional record
- NPI
- 1467409763
- Licence
- CA A66069California A66069: Current · expires 2027-09-30
- Trained
- Stanford University School of Medicine, 1997
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-05-30
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.